Arena Pharma (ARNA) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Arena Pharma (ARNA) Taps Epirus Biopharma's Munshi as CEO
May 9, 2016 4:07 PM EDTArena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced that it has appointed Amit D. Munshi as President, Chief Executive Officer and interim principal financial officer, effective May 11, 2016. Mr. Munshi will also join Arena's Board of Directors following Arena's 2016 annual stockholders' meeting, which is scheduled for June 13, 2016.
Mr. Munshi brings to Arena more than 25 years of global biopharmaceutical industry experience in executive management, business development, product development and portfolio management. Harry F. Hixson, Jr., Ph.D., who has served as Arena's interim Chief Executive Officer and interim principal financial officer since October 2015 and as a... More
